Valid adjustment of randomized comparisons for binary covariates

Biometrical Journal

Volumn 46, Issue 5, 2004, Pages 589-594

  Berger, Vance W ^a  

^a UNIVERSITY OF MARYLAND BALTIMORE COUNTY   (United States)

Author keywords

Principal stratification; Simpson's paradox; Time varying covariate

Indexed keywords

COVARIATES; PRINCIPAL STRATIFICATION; RANDOMISATION; RANDOMIZED TRIAL; SIMPSON; SIMPSON PARADOX; STAGE MIGRATION; TIME VARYING; TIME-VARYING COVARIATE; TREATMENT EFFECTS;

RANDOM PROCESSES;

EID: 19644400778     PISSN: 03233847     EISSN: None     Source Type: Journal    
DOI: 10.1002/bimj.200410055     Document Type: Article

References (20)

1. Berger, V. W. (2004A). Selection bias and baseline imbalances in randomized trials. Drug Information Journal 38, 1-2.
2. Berger, V. W. (2004B). Does the Prentice criteria validate surrogate endpoints? Statistics in Medicine 23, 1571-1578.
3. Berger, V. W., Christophi, C. A. (2003). Randomization technique, allocation concealment, masking, and susceptibility of trials to selection bias. Journal of Modern Applied Statistical Methods 2, 80-86.
4. Berger V. W., Exner D. V. (1999). Detecting selection bias in randomized clinical trials. Controlled Clinical Trials 20, 319-327.
5. Berger, V. W., Ivanova, A., Deloria-Knoll, M. (2003). Enhancing allocation concealment through less restrictive randomization procedures. Statistics in Medicine 22, 3017-3028.
6. Berger, V. W., Rezvani, A., Makarewicz, V. (2003). Direct effect on validity of response run-in selection in clinical trials. Controlled Clinical Trials 24, 156-166.
7. Berger, V. W. et al. (2004). Adjusting for ordinal covariates by inducing a partial ordering. Biometrical Journal 46, 48-55.
8. Carroll, R. J. (1989). Covariance analysis in generalized linear measurement error models. Statistics in Medicine 8, 1075-1093.
9. Committee for Proprietary Medicinal Products (2003). Points to Consider on Adjustment for Baseline Covariates. CPMP/EWP/2863/99, http://www.emea.eu.int/ pdfs/human/ewp/286399en.pdf.
10. Feinstein, A., Sosin, D., Wells, C. (1985). The Will Rogers phenomenon: Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer. New England Journal of Medicine 312, 1604-1608.
11. Frangakis, C. E., Rubin, D. B. (2002). Principal stratification in causal inference. Biometrics 58, 21-29.
12. Huusko, T. M. et al. (2000). Randomised, clinically controlled trial of intensive geriatric rehabilitation in patients with hip fracture: Subgroup analysis of patients with dementia. British Medical Journal 213, 1107-1111.
13. Kalbfleisch, J. D., Prentice, R. L. (1980). The Statistical Analysis of Failure Time Data, Wiley, New York.
14. Lindley, D. V., Novick, M. R. (1981). The role of exchangeability in inference. Annals of Statistics 9, 45-58.
15. Prorok, P. C., Hankey, B. F., Bundy, B. N. (1981). Concepts and problems in the evaluation of screening programs. Journal of Chronic Diseases 34, 159-171.
16. Robins, J. M., Greenland, S. (1994). Adjusting for differential rates of prophylaxis therapy for PCP in high- vs. low-dose AZT treatment arms in an AIDS randomized trial. Journal of the American Statistical Association 89, 737-749.
17. SOLVD Investigators (1991). Effect of Enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. New England Journal of Medicine 325, 293-302.
18. Voutilainen, P. E. (2001). Assessment of grouping variable should have been blind in trial of dementia. British Medical Journal 322, 1491.
19. Wang, S. J., Hung, H. M. J. (2003). Assessing Treatment Efficacy in Noninferiority Trials. Controlled Clinical Trials 24, 147-155.
20. Yusuf, S. et al. (1991). Analysis and interpretation of treatment effects in subgroups of patients in randomized clinical trials. Journal of the American Medical Association 266, 93-98.